Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Merlino

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Microbiology|May 18, 2023
The identification of the new species <i>Nitratireductor thuwali</i> sp. nov. reveals the untapped diversity of hydrocarbon-degrading culturable bacteria from the arid mangrove sediments of the Red SeaRamona Marasco, Grégoire Michoud, Fatmah O Sefrji, et al.
Journal of Cellular Physiology|March 10, 2018
Extracellular matrix proteins as diagnostic markers of breast carcinomaMarta Giussani, Elena Landoni, Giuseppe Merlino, et al.
Microbiome|December 6, 2018
Rhizosheath microbial community assembly of sympatric desert speargrasses is independent of the plant hostRamona Marasco, María J Mosqueira, Marco Fusi, et al.
Microbiology Spectrum|June 1, 2022
Bioturbation Intensity Modifies the Sediment Microbiome and Biochemistry and Supports Plant Growth in an Arid Mangrove SystemMarco Fusi, Jenny Marie Booth, Ramona Marasco, et al.
Scientific Reports|January 24, 2020
Discovery of Afifi, the shallowest and southernmost brine pool reported in the Red SeaCarlos M Duarte, Anders Røstad, Grégoire Michoud, et al.
Frontiers in Oncology|November 30, 2023
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathwayGiuliana Papoff, Dario Presutti, Valentina Fustaino, et al.
Breast Cancer Research and Treatment|March 13, 2023
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancerAlessio Fiascarelli, Giuseppe Merlino, Stefania Capano, et al.
Journal of Cellular and Molecular Medicine|December 9, 2024
The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3-ITD-Mutant Acute Myeloid LeukaemiaSonia Zicari, Giuseppe Merlino, Alessandro Paoli, et al.
Molecular Cancer Therapeutics|June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid TumorsGiuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Haematologica|November 2, 2020
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma modelsEugenio Gaudio, Chiara Tarantelli, Filippo Spriano, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Microbiology|May 18, 2023
The identification of the new species <i>Nitratireductor thuwali</i> sp. nov. reveals the untapped diversity of hydrocarbon-degrading culturable bacteria from the arid mangrove sediments of the Red SeaRamona Marasco, Grégoire Michoud, Fatmah O Sefrji, et al.
Journal of Cellular Physiology|March 10, 2018
Extracellular matrix proteins as diagnostic markers of breast carcinomaMarta Giussani, Elena Landoni, Giuseppe Merlino, et al.
Microbiome|December 6, 2018
Rhizosheath microbial community assembly of sympatric desert speargrasses is independent of the plant hostRamona Marasco, María J Mosqueira, Marco Fusi, et al.
Microbiology Spectrum|June 1, 2022
Bioturbation Intensity Modifies the Sediment Microbiome and Biochemistry and Supports Plant Growth in an Arid Mangrove SystemMarco Fusi, Jenny Marie Booth, Ramona Marasco, et al.
Scientific Reports|January 24, 2020
Discovery of Afifi, the shallowest and southernmost brine pool reported in the Red SeaCarlos M Duarte, Anders Røstad, Grégoire Michoud, et al.
Frontiers in Oncology|November 30, 2023
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathwayGiuliana Papoff, Dario Presutti, Valentina Fustaino, et al.
Breast Cancer Research and Treatment|March 13, 2023
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancerAlessio Fiascarelli, Giuseppe Merlino, Stefania Capano, et al.
Journal of Cellular and Molecular Medicine|December 9, 2024
The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3-ITD-Mutant Acute Myeloid LeukaemiaSonia Zicari, Giuseppe Merlino, Alessandro Paoli, et al.
Molecular Cancer Therapeutics|June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid TumorsGiuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Haematologica|November 2, 2020
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma modelsEugenio Gaudio, Chiara Tarantelli, Filippo Spriano, et al.
Pageof 3